Business
Novonesis delivered 8% organic sales growth in the first nine months of 2025
Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards. COPENHAGEN, Denmark – November 6, 2025. Novonesis delivered 8% organic sales growth in the first nine months of 2025. Full-year outlook is narrowed upwards to 7-8%, previously 6-8%. Ester Baiget, President & CEO: "I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability. Our performance was strong across all sa
About this update from Novonesis A/s Class B
[{"type":"image","alt":"Novonesis (Novozymes A/S)","displaySize":"","headline":null,"caption":"Novonesis (Novozymes A/S)","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":38,"url":"https://media.zenfs.com/en/globenewswire.com/d587064c2241c08df4f2bac0e72e38fb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/zKklvML9_v1QAJVxEtCwVg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUzO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/d587064c2241c08df4f2bac0e72e38fb","width":300,"height":38}},"lazy":false},{"type":"text","content":"Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards.","length":116,"tagName":"p"},{"type":"text","content":"COPENHAGEN, Denmark – November 6, 2025. Novonesis delivered 8% organic sales growth in the first nine months of 2025. Full-year outlook is narrowed upwards to 7-8%, previously 6-8%.","length":181,"tagName":"p"},{"type":"text","content":"Ester Baiget, President & CEO:","length":34,"tagName":"p"},{"type":"text","content":""I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability. Our performance was strong across all sales areas and in emerging and developed markets. We delivered 37.3% adjusted EBITDA margin, despite significant currency headwinds, demonstrating the strength and resilience of our business model. Following a robust nine-months performance including favorable timing in the third quarter, we indicate mid-single-digit organic sales growth for the fourth quarter and lift the bottom end of the range now expecting 7-8% for the full year. We continue to execute on our strategic priorities, positioning us firmly to deliver on our 2030 targets." Highlights of our 9M results:","length":760,"tagName":"p"},{"type":"text","content":"- Strong broad-based organic sales growth of 8% (Q3: 6%), including the negative impact of exiting certain countries of ~1 percentage point (Q3: ~2 percentage points). Price contributed by ~1 percentage point (Q3: ~1 percentage point).- Food & Health at 9% organic sales growth (Q3: 6%) including the negative impact of exiting certain countries of ~2 percentage points (Q3: ~5 percentage points). Planetary Health at 8% organic sales growth (Q3: 6%).- Emerging Markets at 12% organic sales growth (Q3: 10%); Devel...